retatrutide clinical trial phase retatrutide Eli Lilly's 3 studies investigating retatrutide, the "triple-G" agonist, have found that long-term use can achieve substantial weight loss. Read about the work via the link in the comments Buy Retatrutide — Best Research

Severe gastrointestinal condition (gastroparesis, inflammatory bowel disease) 10

The documented efficacy in diabetes management and the considerable cardiovascular advantages associated with particular GLP-1 agonists are two key drivers moving this industry ahead

GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial

For example, a 2019 study found that eating a whole avocado with a meal elevated levels of GLP-1 and peptide YY (another hormone tied to fullness), while also lowering insulin levels

Consumer platforms like Weight Watchers and Noom now integrate GLP-1 prescribing into coaching and nutrition programs, reframing them as part of holistic lifestyle care